By Alexis Lee, News Writer
The Advanced Construction and Materials Laboratory (ACML) is one giant step closer to its goal thanks to the generous donation given by the Sunderland Foundation, the charitable arm of the Ash Grove Cement Company. The ACML, held in Butler-Carlton Hall, is seeking six million dollars worth of improvement to help benefit research in areas of buildings, civil, power infrastructure, and infrastructure management, and the Sunderland Foundation offered the university one hundred thousand dollars to support these efforts.
By Heather Pribil, News Writer
Photo Source: http://www.clipartbest.com/clipart-jcxpgg7gi
Cancer screening techniques first began development in the 1920s with the discovery of the Pap test. Once this test achieved widespread usage in the early 1960s, the death rate due to cervical cancer fell by 70 percent. Modern mammography methods were first developed in the 1960s and brought to widespread attention by the 1970s. It is the most common form of screening for breast cancer as many other techniques can be invasive or slow. Dr. Yinfa Ma, Curators’ Teaching Professor of Chemistry and Associate Dean for Research and External Relations in the College of Arts, Sciences, and Business (CASB) at Missouri University of Science and Technology, has been researching biomarkers for early cancer detection for years.
The product of this research, the “P-Scan,” is a new breast cancer screening method which uses urinalysis to diagnose the presence and severity of breast cancer in a patient. The device is a noninvasive, rapid, point-of-care test for early screening of cancer which monitors levels of pteridine biomarkers in urine. The P-Scan works by passing the collected urine through a small capillary and detecting the fluorescence given off by the pteridine biomarkers. One advantage of this technique is that it delivers sensitivity without costly instrumentation. Once the method was developed, Dr. Ma expanded his research in 2013 to hundreds of patients at Mercy Breast Center in Springfield, Missouri to determine its effectiveness and make this method of pre-screening available in clinics around the United States. The study has been concluded, and the device will be receiving a patent and wide spread commercialization, meaning that it may replace the mammogram as the most common form of breast cancer screening.
By Grace Deitzler, News Writer
Just six hours after University of Missouri System President Tim Wolfe announced his resignation, MU Chancellor R. Bowen Loftin announced his own resignation from the position of Chancellor, effective at the end of this year.
Pressure for Wolfe and Loftin to step down has been building due to the administration’s poor handling of recent events surrounding racial issues. Though tensions had been rising since the events in Ferguson last year, the boiling point was reached earlier this semester when racial slurs were directed towards student body president Payton Head. Following this, the Legion of Black Collegiates was rehearsing a homecoming play and were verbally assaulted by a white man interrupting their rehearsal and yelling racial slurs at the students.
Tim Wolfe, left, and R. Bowen Loftin, right.